What We Treat | Virta Health

The majority of US adults live with a chronic metabolic health condition.¹ Virta can help.

Virta has a treatment for everyone, wherever they are on the metabolic health spectrum.

Diabetes Reversal

Safely deprescribe diabetes medications and return blood sugar to subdiabetic levels.

For patients with type 2 diabetes, ready to reverse.

Diabetes Management

Monitor and control blood sugar, provide app-based educational content.

For type 2 patients not ready to reverse, and type 1.

Prediabetes Reversal

Return blood sugar to sub-prediabetic levels and deliver clinically significant weight loss.

For patients with prediabetes (A1c level of 5.7 to 6.4).

Obesity Treatment

Deliver clinically significant weight loss of 5–12% for patients struggling with obesity.

For patients with BMI > 30.

Virta’s provider-led treatments deliver unmatched outcomes.

1.3%

A1c reduction at 1 year²

Clinical trial data

59%

Rx elimination at 1 year²

Clinical trial data

$10,400

Projected cost savings per patient at 2 years³

30 lbs

Avg Weight Loss at 2 years⁴

$3,000

Estimated cost savings per patient at 2 years⁵

97%

Patients avoided progression to T2D over 2 years⁴

$4,200

Cost savings per patient at 2 years⁶

You’re not alone on your journey toward better metabolic health. Meet our patients.

Kim lost 75 pounds and has kept it off for 3 years

“...this is the first time ever in my life that my stomach has communicated with my brain to say, "Stop, I'm full."

Watch Kim's story

Kevin got off insulin and saved $500/month

“I run around with my kids a lot more than I did six months ago. I feel like I’m 15 years younger.”

Watch Kevin's story

Donnie reduced his medications in a matter of weeks

“Where I used to take 3 different types of insulin every day for a total of 110 units, I am now down to just 3 units of Basaglar.”

Read Donnie's story

Citations and Footnotes

Centers for Disease Control and Prevention. National Diabetes Statistics Report website. https://www.cdc.gov/diabetes/data/statistics-report/index.html. Accessed May 12, 2022.
Hallberg SJ et al. Diabetes Ther. 2018; 9(2): 583-612. Outcomes among one year completers (83% retention in Virta Treatment; 90% retention in Standard Care). Rx refers to the net change in diabetes-specific prescription volume at one year (which excludes metformin) compared to baseline and multiple insulins prescribed to a patient were counted as one Rx.
Virta Health, Analysis of Type 2 Diabetes Reversal Cost Savings, Sept 2021 (Virta)
McKenzie AL et al. Nutrients. 2021:13(3):749
Cawley, John et al. “Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status.” PharmacoEconomics vol. 33,7 (2015): 707-22. doi:10.1007/s40273-014-0230-2. ROI was estimated using Virta’s standard PPPM pricing and the projected savings from the source referenced. Model available upon request.
T Khan. Medical Care Expenditures for Individuals with Prediabetes: The Potential Cost Savings in Reducing the Risk of Developing Diabetes. Popul Health Manag. 2017 Oct;20(5):389-396. doi: 10.1089/pop.2016.0134. Epub 2017 Feb 13. ROI was estimated using Virta’s standard PPPM pricing and the projected savings from the source referenced. Model available upon request.

Virta addresses the full spectrum of metabolic health needs of your population